机构:[1]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China广东省中医院[2]The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
Genetic alterations in K-ras and p53 are thought to be critical in pancreatic cancer development and progression. However, K-ras and p53 expression in pancreatic adenocarcinoma have not been systematically examined in The Cancer Genome Atlas (TCGA) Data Portal. Information regarding K-ras and p53 alterations, mRNA expression data, and protein/protein phosphorylation abundance was retrieved from The Cancer Genome Atlas (TCGA) databases, and analyses were performed by the cBioPortal for Cancer Genomics. The mutual exclusivity analysis showed that events in K-ras and p53 were likely to co-occur in pancreatic adenocarcinoma (Log odds ratio = 1.599, P = 0.006). The graphical summary of the mutations showed that there were hotspots for protein activation. In the network analysis, no solid association between K-ras and p53 was observed in pancreatic adenocarcinoma. In the survival analysis, neither K-ras nor p53 were associated with both survival events. As in the data mining study in the TCGA databases, our study provides a new perspective to understand the genetic features of K-ras and p53 in pancreatic adenocarcinoma.
基金:
Guangdong Natural Science FoundationNational Natural Science Foundation of Guangdong Province [2016A030310290]; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine [YN2015QN20]
第一作者机构:[1]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China
推荐引用方式(GB/T 7714):
Lu Liming,Zeng Jingchun.Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas[J].PLOS ONE.2017,12(7):doi:10.1371/journal.pone.0181532.
APA:
Lu, Liming&Zeng, Jingchun.(2017).Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.PLOS ONE,12,(7)
MLA:
Lu, Liming,et al."Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas".PLOS ONE 12..7(2017)